Novel thienopyrimidine derivatives as dual EGFR and VEGFR-2 inhibitors: design, synthesis, anticancer activity and effect on cell cycle profile
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel thienopyrimidine derivatives as dual EGFR and VEGFR-2 inhibitors: design, synthesis, anticancer activity and effect on cell cycle profile
Authors
Keywords
-
Journal
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
Volume 34, Issue 1, Pages 838-852
Publisher
Informa UK Limited
Online
2019-03-28
DOI
10.1080/14756366.2019.1593160
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synthesis of Novel Thieno[2,3-d]pyrimidine Derivatives and Evaluation of Their Cytotoxicity and EGFR Inhibitory Activity
- (2018) Ehab Mohamed Gedawy Anti-Cancer Agents in Medicinal Chemistry
- Design, synthesis and anticancer evaluation of 1 H -pyrazolo[3,4- d ]pyrimidine derivatives as potent EGFR WT and EGFR T790M inhibitors and apoptosis inducers
- (2018) Ahmed A. Gaber et al. BIOORGANIC CHEMISTRY
- Risk of rash associated with vandetanib treatment in non-small-cell lung cancer patients
- (2017) Yuan Liu et al. MEDICINE
- Synthesis and biological evaluation of di-aryl urea derivatives as c-Kit inhibitors
- (2015) Séverine Ravez et al. BIOORGANIC & MEDICINAL CHEMISTRY
- New Frontiers in Kinases: Second Generation Inhibitors
- (2014) Stefan Laufer et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and anticancer activity of novel 2-pyridyl hexahyrocyclooctathieno[2,3-d]pyrimidine derivatives
- (2013) Asmaa E. Kassab et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Novel 2-chloro-4-anilino-quinazoline derivatives as EGFR and VEGFR-2 dual inhibitors
- (2013) Maria Letícia de Castro Barbosa et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Targeted therapy against EGFR and VEGFR using ZD6474 enhances the therapeutic potential of UV-B phototherapy in breast cancer cells
- (2013) Siddik Sarkar et al. Molecular Cancer
- Role of epidermal growth factor receptor in breast cancer
- (2012) Hiroko Masuda et al. BREAST CANCER RESEARCH AND TREATMENT
- Vascular Endothelial Growth Factor (VEGF) Receptors: Drugs and New Inhibitors
- (2012) Francesca Musumeci et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis and Structure–Activity Relationships of (Aryloxy)quinazoline Ureas as Novel, Potent, and Selective Vascular Endothelial Growth Factor Receptor-2 Inhibitors
- (2012) Antonio Garofalo et al. JOURNAL OF MEDICINAL CHEMISTRY
- Phase I Study of Cetuximab, Irinotecan, and Vandetanib (ZD6474) as Therapy for Patients with Previously Treated Metastastic Colorectal Cancer
- (2012) Jeffrey A. Meyerhardt et al. PLoS One
- Molecular conformations, interactions, and properties associated with drug efficiency and clinical performance among VEGFR TK inhibitors
- (2012) M. McTigue et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- EGFR Signals Downregulate Tumor Suppressors miR-143 and miR-145 in Western Diet-Promoted Murine Colon Cancer: Role of G1 Regulators
- (2011) H. Zhu et al. MOLECULAR CANCER RESEARCH
- ZD6474, a dual tyrosine kinase inhibitor of EGFR and VEGFR-2, inhibits MAPK/ERK and AKT/PI3-K and induces apoptosis in breast cancer cells
- (2010) Siddik Sarkar et al. CANCER BIOLOGY & THERAPY
- Pharmacophore modeling and virtual screening studies for new VEGFR-2 kinase inhibitors
- (2010) Kyungik Lee et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Vandetanib for the Treatment of Patients With Locally Advanced or Metastatic Hereditary Medullary Thyroid Cancer
- (2010) Samuel A. Wells et al. JOURNAL OF CLINICAL ONCOLOGY
- Quinazoline-urea, new protein kinase inhibitors in treatment of prostate cancer
- (2010) Antonio Garofalo et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Differential roles of ERK and Akt pathways in regulation of EGFR-mediated signaling and motility in prostate cancer cells
- (2010) Y Gan et al. ONCOGENE
- [4-(6,7-Disubstituted quinazolin-4-ylamino)phenyl] carbamic acid esters: a novel series of dual EGFR/VEGFR-2 tyrosine kinase inhibitors
- (2010) Antonio Garofalo et al. MedChemComm
- Design, synthesis and in vitro antitumor activity of 4-aminoquinoline and 4-aminoquinazoline derivatives targeting EGFR tyrosine kinase
- (2008) Khaled Abouzid et al. BIOORGANIC & MEDICINAL CHEMISTRY
- New developments in multitargeted therapy for patients with solid tumours
- (2008) C. Le Tourneau et al. CANCER TREATMENT REVIEWS
- Targeting EGFR activity in blood vessels is sufficient to inhibit tumor growth and is accompanied by an increase in VEGFR-2 dependence in tumor endothelial cells
- (2008) Dhara N. Amin et al. MICROVASCULAR RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started